European Commission Approves RELVAR ELLIPTA To Treat Asthma And COPD

Home › European Commission Approves RELVAR ELLIPTA To Treat Asthma And COPD

RELVAR® ELLIPTA® has been given marketing authorization by the European Commission for the treatment of asthma and COPD.

03.07	Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07	Keep livestock safe during hurricane season with an emergency plan
03.07	Making the most of forage resources
03.07	Summary for Hurricane Beryl (AT2/AL022024)
02.07	Hurricane Beryl Graphics
02.07	Hurricane Beryl Forecast Discussion Number 17
02.07	Hurricane Beryl Forecast Advisory Number 17
02.07	Ansell Completes Acquisition of Kimberly-Clarks PPE Business
More »

je.st